Insud Pharma

For profitWebsite ↗

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

May 1, 2013

Last known activity

Oct 31, 2025

Timeline

1940s

Jun 1, 1940
Insud Pharma— Founded

Drugs by trial phase (19 distinct, 24 trials)

Phase 4 (1 own, 0 via acquisition)

drospirenone

Phase 3 (16 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

oxytocin

Phase 1 (1 own, 0 via acquisition)

palivizumab

Indications

Studied for

Recent trials (27)

NCT07221734Lead sponsorPhase 3Oct 31, 2025
NCT06968481Lead sponsorPhase 2Oct 1, 2025
NCT06687369Lead sponsorPhase 3Dec 31, 2024
NCT06596772Lead sponsorPhase 3Sep 11, 2024
NCT06392074Lead sponsorPhase 1Mar 7, 2024
NCT05461573Lead sponsorPhase 3Aug 2, 2022
NCT05338086Lead sponsorPhase 3Mar 31, 2022
NCT05303636Lead sponsorPhase 4Mar 28, 2022
NCT05299073Lead sponsorPhase 1Mar 1, 2022
NCT05121246Lead sponsorPhase 1Jan 31, 2022
NCT05993143Lead sponsorPhase 3Jan 18, 2021
NCT04408989Lead sponsorPhase 1Jul 14, 2020
NCT04540627Lead sponsorPhase 1Jul 6, 2020
NCT04238663Lead sponsorPhase 1Sep 9, 2019
NCT03945513Lead sponsorPhase 3Aug 31, 2019

Details

Founded: Madrid, ES Jun 1, 1940
Last known activity: Oct 31, 2025

Notes

Combination of: mAbxience S.A Exeltis USA, Inc. Chemo Group --- Pre-folding founded info: 1977-07-01 Buenos Aires AR https://en.wikipedia.org/wiki/Grupo_Insud ---